![“Key strategy of ICARS is to develop and test context-specific solutions for AMR mitigation" “Key strategy of ICARS is to develop and test context-specific solutions for AMR mitigation"](https://cdn.magzter.com/1444374281/1688384066/articles/CXG40gmZj1688421050111/KEY-STRATEGY-OF-ICARS-IS-TO-DEVELOP-AND-TEST-CONTEXTSPECIFIC-SOLUTIONS-FOR-AMR-MITIGATION.jpg)
In your opinion, which APAC countries have shown significant progress in addressing AMR? What specific measures or interventions have contributed to their success?
The Asia Pacific region, home to two-thirds of the world’s population and ten of the least developed countries, is considered a regional hot-spot for the emergence and spread of antimicrobial resistance (AMR). WHO analysis data indicates that over 90 per cent of the APAC countries have developed their AMR-national action plans (NAPs) and nearly 50 per cent of them have operationalised and implemented them. AMR requires a multisectoral approach focussing on governance, regulation and standards for AMR; a comprehensive, integrated national surveillance system; antimicrobial stewardship and measures to reduce antibiotic use; well structured systematic infection prevention and control programmes; research and development; and education, communication and stakeholder engagement. The emphasis has to be on how the Universal Health Coverage strategies should integrate AMR challenges. An analysis of implementation of NAPs indicates that the APAC countries have successfully achieved the implementation of key indicators of human and animal health. However, environmental factors, plant health, food safety require more efforts for integration into the NAP strategic plans.
Diese Geschichte stammt aus der July 2023-Ausgabe von BioSpectrum Asia.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent ? Anmelden
Diese Geschichte stammt aus der July 2023-Ausgabe von BioSpectrum Asia.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent? Anmelden
![Prof. Christian Wolfrum to join NTU as Deputy President and Provost Prof. Christian Wolfrum to join NTU as Deputy President and Provost](https://reseuro.magzter.com/100x125/articles/11639/1979239/aFQSj2cXo1738327652897/PROF-CHRISTIAN-WOLFRUM-TO-JOIN-NTU-AS-DEPUTY-PRESIDENT-AND-PROVOST.jpg)
Prof. Christian Wolfrum to join NTU as Deputy President and Provost
Nanyang Technological University, Singapore (NTU Singapore) has announced that Professor Christian Wolfrum, an eminent biomedical scientist, will be joining the University as the next Deputy President and Provost.
![Japan suggests addition of PVA into drugs for strong antitumour activity Japan suggests addition of PVA into drugs for strong antitumour activity](https://reseuro.magzter.com/100x125/articles/11639/1979239/L7QBK8c9t1738327954522/JAPAN-SUGGESTS-ADDITION-OF-PVA-INTO-DRUGS-FOR-STRONG-ANTITUMOUR-ACTIVITY.jpg)
Japan suggests addition of PVA into drugs for strong antitumour activity
Treatment for more advanced and difficult-to-treat head and neck cancers can be improved with the addition of polyvinyl alcohol (PVA), the same ingredient used in children's glue.
!["Demand for skilled medtech professionals in the Asia Pacific region is growing rapidly" "Demand for skilled medtech professionals in the Asia Pacific region is growing rapidly"](https://reseuro.magzter.com/100x125/articles/11639/1979239/Bh4IoWqD71738326641256/DEMAND-FOR-SKILLED-MEDTECH-PROFESSIONALS-IN-THE-ASIA-PACIFIC-REGION-IS-GROWING-RAPIDLY.jpg)
"Demand for skilled medtech professionals in the Asia Pacific region is growing rapidly"
2024 saw Japanese medtech firm Olympus receiving approval for the company's first cloud-based AI endoscopy devices in the US and Europe, marking a significant milestone in Olympus' efforts to enhance clinical outcomes and operational efficiency in endoscopy, paving the way to launch its upcoming endoscopy solution, the “Intelligent Endoscopy Ecosystem”.
![BeiGene names Giancarlo Benelli as Head of Europe biz BeiGene names Giancarlo Benelli as Head of Europe biz](https://reseuro.magzter.com/100x125/articles/11639/1979239/dtWtyXs321738327727847/BEIGENE-NAMES-GIANCARLO-BENELLI-AS-HEAD-OF-EUROPE-BIZ.jpg)
BeiGene names Giancarlo Benelli as Head of Europe biz
BeiGene, a Hong Kong-headquartered oncology company that intends to change its name to BeOne Medicines Ltd., has announced the appointment of Giancarlo Benelli as Senior Vice President and Head of Europe, effective January 1.
![Korea develops innovative injectable adhesive hydrogel for bone regeneration Korea develops innovative injectable adhesive hydrogel for bone regeneration](https://reseuro.magzter.com/100x125/articles/11639/1979239/3Ds0USfx91738327790862/KOREA-DEVELOPS-INNOVATIVE-INJECTABLE-ADHESIVE-HYDROGEL-FOR-BONE-REGENERATION.jpg)
Korea develops innovative injectable adhesive hydrogel for bone regeneration
A research team from South Korea-based Pohang University of Science and Technology or POSTECH's Department of Chemical Engineering and Graduate School of Convergence Science and Technology, along with the Department of Chemical Engineering, has developed an innovative injectable adhesive hydrogel for bone regeneration.
![When Clinical Trials Suffer From 'Complicated' Interactions When Clinical Trials Suffer From 'Complicated' Interactions](https://reseuro.magzter.com/100x125/articles/11639/1979239/NXkS_2pHM1738327122349/WHEN-CLINICAL-TRIALS-SUFFER-FROM-COMPLICATED-INTERACTIONS.jpg)
When Clinical Trials Suffer From 'Complicated' Interactions
Diversity in culture, language, and data gathering methods will further increase the difficulty of clinical trials as they become more international, particularly with the growing number of sites being employed across China, Japan, South Korea, and India.
![Dr Krishna M Ella receives prestigious INSA India fellowship Dr Krishna M Ella receives prestigious INSA India fellowship](https://reseuro.magzter.com/100x125/articles/11639/1979239/ewbWvQ-3l1738327520276/DR-KRISHNA-M-ELLA-RECEIVES-PRESTIGIOUS-INSA-INDIA-FELLOWSHIP.jpg)
Dr Krishna M Ella receives prestigious INSA India fellowship
Dr Krishna Ella, a distinguished scientist, co-founder and Executive Chairman of Bharat Biotech International, has been recognised with the prestigious India Fellowship of the Indian National Science Academy (INSA) for the year 2025, for his contributions to new knowledge, discoveries, development of new vaccine technologies, noteworthy improvement in existing technologies.
![Bruker launches infrared imaging microscope for pharma and life science research Bruker launches infrared imaging microscope for pharma and life science research](https://reseuro.magzter.com/100x125/articles/11639/1979239/AOv9T23_N1738328062423/BRUKER-LAUNCHES-INFRARED-IMAGING-MICROSCOPE-FOR-PHARMA-AND-LIFE-SCIENCE-RESEARCH.jpg)
Bruker launches infrared imaging microscope for pharma and life science research
US-based Bruker Corporation has announced the launch of the LUMOS II ILIM, a quantum cascade laser (QCL) based infrared (IR) imaging microscope.
![Qiagen increases QIAcuity digital PCR high-order multiplexing capabilities Qiagen increases QIAcuity digital PCR high-order multiplexing capabilities](https://reseuro.magzter.com/100x125/articles/11639/1979239/vrAMheQwA1738328031280/QIAGEN-INCREASES-QIACUITY-DIGITAL-PCR-HIGHORDER-MULTIPLEXING-CAPABILITIES.jpg)
Qiagen increases QIAcuity digital PCR high-order multiplexing capabilities
Qiagen has announced a significant increase in the powerful capabilities of its QIAcuity Digital PCR (dPCR) system with a more than two-fold increase in the number of targets that can be simultaneously analysed from a single biological sample.
![Repligen unveils advanced UV-based Variable Pathlength Technology system for biopharma manufacturers Repligen unveils advanced UV-based Variable Pathlength Technology system for biopharma manufacturers](https://reseuro.magzter.com/100x125/articles/11639/1979239/5sZt4mdv41738328195356/REPLIGEN-UNVEILS-ADVANCED-UVBASED-VARIABLE-PATHLENGTH-TECHNOLOGY-SYSTEM-FOR-BIOPHARMA-MANUFACTURERS.jpg)
Repligen unveils advanced UV-based Variable Pathlength Technology system for biopharma manufacturers
US-based Repligen Corporation has announced the commercial launch of its CTech SoloVPE PLUS System, the most advanced UV-based Variable Pathlength Technology system now available to biopharmaceutical manufacturers.